Sagimet Biosciences Inc. Series A Common Stock (SGMT) — Defensive Interval Ratio
Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a Defensive Interval Ratio of 5000 days as of June 2026. Defensive assets of $74.23 Million (cash $-, short-term investments $74.23 Million, receivables $-) cover 5000 days of daily cash needs of $14.85K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Sagimet Biosciences Inc. Series A Common Stock Defensive Interval Ratio (2021–2025)
This chart shows how Sagimet Biosciences Inc. Series A Common Stock's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 5000 days, meaning defensive assets of $74.23 Million can fund 5000 days of operations without new revenue. For the complete balance sheet picture, see SGMT total asset value.
Annual Defensive Interval Ratio for Sagimet Biosciences Inc. Series A Common Stock (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Sagimet Biosciences Inc. Series A Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Sagimet Biosciences Inc. Series A Common working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 5589 days | $78.10 Million | $13.98K/day | $- | $78.10 Million | ▼ -591 days |
| 2024 | 6180 days | $75.41 Million | $12.20K/day | $- | $75.41 Million | ▲ +4904 days |
| 2023 | 1275 days | $19.76 Million | $15.49K/day | $- | $19.76 Million | ▼ -950 days |
| 2022 | 2225 days | $32.19 Million | $14.46K/day | $- | $32.19 Million | ▲ +2225 days |
| 2021 | 0 days | $0.00 | $6.68K/day | $- | $0.00 | — |